MDS clinical diagnostic criteria for Parkinson’s disease

Cited by (1,019)

Items 201–300 of 1,019

1. Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder
   Álex Iranzo, Angela Mammana, Amaia Muñoz Lopetegi, Sofia Dellavalle, Gerard Mayà, Marcello Rossi, Mónica Serradell, Simone Baiardi, Aurora Arqueros, Corinne Quadalti et al. · 2023 · Neurology
2. Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson’s disease patients
   Gen Li, Pei Huang, Shishuang Cui, Yu-Yan Tan, Xin Shen, Xin Shen, Qin-Ying Jiang, Ping Huang, Gui-Ying He, Binyin Li et al. · 2022 · Translational Neurodegeneration
3. Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
   Anant Dadu, Vipul K. Satone, Rachneet Kaur, Sayed Hadi Hashemi, Hampton L. Leonard, Hirotaka Iwaki, Mary B. Makarious, Kimberley J. Billingsley, Sara Bandrés‐Ciga, Lana J. Sargent et al. · 2022 · npj Parkinson s Disease
4. Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
   Giovanni Bellomo, Andrea Toja, Federico Paolini Paoletti, Yihua Ma, Carly M. Farris, Lorenzo Gaetani, Nicola Salvadori, Davide Chiasserini, Anna Lidia Wojdała, Luis Concha‐Marambio et al. · 2024 · Alzheimer s & Dementia
5. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
   Nishiwaki, Hiroshi, Ito, Mikako, Hamaguchi, Tomonari, Maeda, Tetsuya, Kashihara, Kenichi, Tsuboi, Yoshio, Ueyama, Jun, Yoshida, Takumi, Hanada, Hiroyuki, Takeuchi, Ichiro et al. · 2022 · npj Parkinson's Disease
6. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease
   Zenghui Cheng, Naying He, Pei Huang, Yan Li, Rongbiao Tang, Sean K. Sethi, Kiarash Ghassaban, Kiran Kumar Yerramsetty, Vinay Kumar Palutla, Shengdi Chen et al. · 2019 · NeuroImage Clinical
7. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
   Florian Lipsmeier, Kirsten I. Taylor, Ronald B. Postuma, Ekaterina Volkova-Volkmar, Timothy Kilchenmann, Brit Mollenhauer, Atieh Bamdadian, Werner Popp, Wei‐Yi Cheng, Yanping Zhang et al. · 2022 · Scientific Reports
8. Computerized analysis of speech and voice for Parkinson's disease: A systematic review
   Quoc Cuong Ngo, Mohammod Abdul Motin, Nemuel Daniel Pah, Peter Drotár, Peter A. Kempster, Dinesh Kumar · 2022 · Computer Methods and Programs in Biomedicine
9. Deep Learning With EEG Spectrograms in Rapid Eye Movement Behavior Disorder
   Giulio Ruffini, David P. Ibañez, Marta Castellano, Laura Dubreuil-Vall, Aureli Soria‐Frisch, Ron Postuma, Jean‐François Gagnon, Jacques Yves Montplaisir · 2019 · Frontiers in Neurology
10. Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
    Christopher H. Gibbons, Ningshan Wang, Sharika Rajan, Drew S. Kern, Jose‐Alberto Palma, Horacio Kaufmann, Roy L. Freeman · 2023 · Neurology
11. Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
    Hugo Vicente Miranda, Rafaela Cássio, Leonor Correia Guedes, Marcos António Gomes, Ana Chegão, Elisa Miranda, Tiago Soares, Miguel M Coelho, Mário Miguel Rosa, Joaquim José Ferreira et al. · 2017 · Scientific Reports
12. Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson’s Disease
    Xiaoli Si, Jun Tian, Yanxing Chen, Yaping Yan, Jiali Pu, Baorong Zhang · 2019 · Neuroscience
13. Enhancing Gamma Oscillations Restores Primary Motor Cortex Plasticity in Parkinson's Disease
    Andrea Guerra, Francesco Asci, Valentina D’Onofrio, Valerio Sveva, Matteo Bologna, Giovanni Fabbrini, Alfredo Berardelli, Antonio Suppa · 2020 · Journal of Neuroscience
14. Functional brain networks in the evaluation of patients with neurodegenerative disorders
    Matej Perovnik, Tomaž Rus, Katharina A. Schindlbeck, David Eidelberg · 2022 · Nature Reviews Neurology
15. Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?
    Sasivimol Virameteekul, Tamás Révész, Zane Jaunmuktane, Thomas T. Warner, Eduardo De Pablo‐Fernández · 2023 · Movement Disorders
16. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
    Nicki Niemann, Joseph J. Jankovic · 2019 · Parkinsonism & Related Disorders
17. Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved
    Diana Denisse Álvarez‐Luquín, Asiel Arce-Sillas, Jaquelín Leyva-Hernández, Edgar E. Sevilla-Reyes, Marie‐Catherine Boll, Esteban Uriel Montes-Moratilla, Viridiana Vivas-Almazán, Citzielli Aseret Pérez-Correa, Ulises Rodríguez-Ortiz, Raquel Espinosa-Cárdenas et al. · 2019 · Journal of Neuroinflammation
18. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease
    Cristina Agliardi, Mario Meloni, Franca Rosa Guerini, Milena Zanzottera, Elisabetta Bolognesi, Francesca Baglio, Mario Clerici · 2020 · Neurobiology of Disease
19. Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder
    Shady Rahayel, Ronald B. Postuma, Jacques Yves Montplaisir, Daphné Génier Marchand, Frédérique Escudier, Malo Gaubert, Pierre-Alexandre Bourgouin, Julie Carrier, Oury Monchi, Sven Joubert et al. · 2018 · Neurology
20. How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder
    Daphné Génier Marchand, Ronald B. Postuma, Frédérique Escudier, Jessie De Roy, Amélie Pelletier, Jacques Yves Montplaisir, Jean‐François Gagnon · 2018 · Annals of Neurology
21. Incidence of Parkinson’s disease in a large patient cohort with idiopathic smell and taste loss
    Antje Haehner, Carla Masala, Sophie Walter, Heinz Reichmann, Thomas R. Hummel · 2018 · Journal of Neurology
22. Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
    Lien Veys, Marjan Vandenabeele, Isabel Ortuño‐Lizarán, Veerle Baekelandt, Nicolás Cuenca, Lieve Moons, Lies De Groef · 2019 · Acta Neuropathologica
23. The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols
    Sunisha Aryal, Taylor Skinner, Bronwyn Bridges, John T. Weber · 2020 · Molecules
24. Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
    Paulina González-Latapí, Ece Bayram, Irene Litvan, Connie Marras · 2021 · Behavioral Sciences
25. Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study
    Cook, Lola, Verbrugge, Jennifer, Schwantes-An, Tae-Hwi, Schulze, Jeanine, Foroud, Tatiana, Hall, Anne, Marder, Karen S, Mata, Ignacio F, Mencacci, Niccolò E, Nance, Martha A et al. · 2024 · Brain
26. Ubiquitin and Receptor-Dependent Mitophagy Pathways and Their Implication in Neurodegeneration
    Lauren E. Fritsch, M. Elyse Moore, Shireen A. Sarraf, Alicia M. Pickrell · 2019 · Journal of Molecular Biology
27. Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
    Daniel Stoessel, Claudia Schulte, Márcia Cristina Teixeira dos Santos, D. Scheller, Irene Rebollo‐Mesa, Christian Deuschle, Dirk Walther, Nicolas Schauer, Daniela Berg, André Nogueira da Costa et al. · 2018 · Frontiers in Aging Neuroscience
28. Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis
    K. Jellinger, G. Logroscino, G. Rizzo, M. Copetti, Simona Arcuti, D. Martino, Andrea Fontana · 2016 · Neurology
29. LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
    Farzaneh Atashrazm, Deborah A. Hammond, Gayathri Perera, Marc F. Bolliger, Elie Matar, Glenda Margaret Halliday, Birgitt Schüle, Simon J.G. Lewis, R. Jeremy Nichols, Nicolas L. Dzamko · 2018 · Movement Disorders
30. Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
    Sanne K. Meles, Remco J. Renken, Marco Pagani, Laura K. Teune, Dario Arnaldi, Silvia Daniela Morbelli, Flavio Mariano Nobili, Teus van Laar, Jose Angel Obeso, María Rodríguez‐Oroz et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
31. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
    Heather Wilson, George Dervenoulas, Gennaro Pagano, Christos Koros, Tayyabah Yousaf, Marina Picillo, Sotirios Polychronis, Athina‐Maria Simitsi, Beniamino Giordano, Zachary Chappell et al. · 2019 · The Lancet Neurology
32. Long-term Risk of Parkinson Disease Following Influenza and Other Infections
    Noelle M. Cocoros, Elisabeth Svensson, Szimonetta Komjáthiné Szépligeti, Søren Viborg Vestergaard, Péter Szentkúti, Reimar Wernich Thomsen, Per Borghammer, Henrik Toft Sørensen, Victor W. Henderson · 2021 · JAMA Neurology
33. Clinical neurophysiology of Parkinson’s disease and parkinsonism
    Robert E. Chen, Alfredo Berardelli, Amitabh Bhattacharya, Matteo Bologna, Kai-Hsiang Stanley Chen, Alfonso A. Fasano, Rick C. G. Helmich, William D. Hutchison, Nitish L. Kamble, Andrea A. Kühn et al. · 2022 · Clinical Neurophysiology Practice
34. Molecular Imaging of the Dopamine Transporter
    Giovanni Palermo, Roberto Ceravolo · 2019 · Cells
35. Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's Disease
    L. Muñoz-Delgado, D. Macías-García, S. Jesús, J. F. Martín-Rodríguez, M. Labrador-Espinosa, María del Valle Jiménez-Jaraba, A. Adarmes-Gómez, F. Carrillo, P. Mir · 2021 · Movement Disorders
36. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
    Motoki Fujimaki, Shinji Saiki, Yuanzhe Li, Naoko Kaga, Hikari Taka, Taku Hatano, Kei‐ichi Ishikawa, Yutaka Oji, Akio Mori, Ayami Okuzumi et al. · 2018 · Neurology
37. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson’s disease
    Christopher E. J. Doppler, Martin Byskov Kinnerup, Corinna Brune, Ezequiel Farrher, Matthew J. Betts, Tatyana Dmitrievna Fedorova, Jeppe L. Schaldemose, Karoline Knudsen, Rola Ismail, Aline Seger et al. · 2021 · Brain
38. Identification of sixteen novel candidate genes for late onset Parkinson’s disease
    Alessandro Gialluisi, Mafalda Giovanna Reccia, Nicola Modugno, Teresa Nutile, Alessia Lombardi, Luca Giovanni Di Giovannantonio, Sara Pietracupa, Daniela Ruggiero, Simona Scala, Stefano Gambardella et al. · 2021 · Molecular Neurodegeneration
39. Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure
    Singer, Wolfgang, Schmeichel, Ann M., Shahnawaz, Mohammad, Schmelzer, James D., Sletten, David M., Gehrking, Tonette L., Gehrking, Jade A., Olson, Anita D., Suarez, Mariana D., Misra, Pinaki P. et al. · 2021 · Annals of Neurology
40. Multiple System Atrophy
    Gregor Karl Wenning, Stefan Braune · 2001 · CNS Drugs
41. Neuromelanin‐sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes
    J. Wang, Yizhu Li, Zhemin Huang, Wenbin Wan, Y. Zhang, Chuan Wang, Xiaoqin Cheng, Fanfan Ye, K Liu, G. Fei et al. · 2018 · European Journal of Neurology
42. Clinical Utility of 18F‐APN ‐1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy
    Ling Li, Fengtao Liu, Ming Li, Jiaying Lu, Yi‐Min Sun, Xiaoniu Liang, Weiqi Bao, Qi-Si Chen, Xinyi Li, Xinyue Zhou et al. · 2021 · Movement Disorders
43. A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population
    Brage Brakedal, Lilah Toker, Kristoffer Haugarvoll, Charalampos Tzoulis · 2022 · npj Parkinson s Disease
44. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
    Mihaila, Dragos, Donegan, Jordan, Barns, Sarah, LaRocca, Daria, Du, Qian, Zheng, Danny, Vidal, Michael, Neville, Christopher, Uhlig, Richard, Middleton, Frank A. · 2019 · PLOS ONE
45. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease
    Dumitrescu, Laura, Marta, Daciana, Dănău, Adela, Lefter, Antonia, Tulbă, Delia, Cozma, Liviu, Manole, Emilia, Gherghiceanu, Mihaela, Ceafalan, Laura Cristina, Popescu, Bogdan Ovidiu · 2021 · Frontiers in Neuroscience
46. Psychostimulant use and the brain
    Julia Lappin, Grant E. Sara · 2019 · Addiction
47. Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
    Aline Delva, Donatienne Van Weehaeghe, Michel J. B. Koole, Koen Van Laere, Wim Vandenberghe · 2020 · Movement Disorders
48. Role of homocysteine in the development and progression of Parkinson’s disease
    Xiaoyan Fan, Lixia Zhang, Haijun Li, Guang Chen, Gangqiao Qi, Xueqiang Ma, Yuelei Jin · 2020 · Annals of Clinical and Translational Neurology
49. Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations
    Omer F. Kuzu, Lars Jørgen Tvenge Granerud, Fahri Saatcioglu · 2025 · Signal Transduction and Targeted Therapy
50. What is Functional Mobility Applied to Parkinson’s Disease?
    Raquel Bouça‐Machado, Walter Maetzler, Joaquim José Ferreira · 2018 · Journal of Parkinson s Disease
51. Value of in vivo α‐synuclein deposits in Parkinson's disease: A systematic review and meta‐analysis
    Kazuto Tsukita, Haruhi Sakamaki‐Tsukita, Kanta Tanaka, Toshihiko Suenaga, Ryōsuke Takahashi · 2019 · Movement Disorders
52. Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
    L. Krajčovičová, Patrícia Klobušiaková, Irena Rektorová · 2019 · Current Neurology and Neuroscience Reports
53. Diagnostic Value of Salivary Real‐Time Quaking‐Induced Conversion in Parkinson's Disease and Multiple System Atrophy
    Mingyue Luan, Yunchuang Sun, Jing Chen, Yanyan Jiang, Fan Li, Luhua Wei, Wei Sun, Jinfa Ma, Lu Song, Jianghong Liu et al. · 2022 · Movement Disorders
54. Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects
    Lynne Krohn, Karl Heilbron, Cornelis Blauwendraat, Regina Hertfelder Reynolds, Eric Yu, Konstantin A. Senkevich, Uladzislau Rudakou, Mehrdad A. Estiar, Emil Karl Gustavsson, Kajsa Atterling Brolin et al. · 2022 · Nature Communications
55. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease
    Jing Zou, Yue Guo, Lei Wei, Fang F. Yu, Bo Yu, Anding Xu · 2020 · Neurotherapeutics
56. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning
    Kristen Severson, Lana M. Chahine, Luba Smolensky, Murtaza Dhuliawala, Mark A. Frasier, Kenney Ng, Soumya Ghosh, Jianying Hu · 2021 · The Lancet Digital Health
57. The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
    Ming‐Che Kuo, Sam Chi-Hao Liu, Ya-Fang Hsu, Ruey‐Meei Wu · 2021 · Journal of Biomedical Science
58. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts
    Andrea Pilotto, Sebastian Heinzel, Ulrike Suenkel, Stefanie Lerche, Kathrin Brockmann, Benjamin Röeben, Eva Schaeffer, Isabel Wurster, Rezzak Yılmaz, Inga Liepelt‐Scarfone et al. · 2017 · Movement Disorders
59. The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?
    Stefan Williams, Zhibin Zhao, Awais Hafeez, David Wong, Samuel David Relton, Hui Fang, Jane Alty · 2020 · Journal of the Neurological Sciences
60. Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
    Rejko Krüger, Jochen Klucken, Daniel Weiß, Lars Tönges, Pierre Luc Kolber, Stefan Unterecker, Michael Lorrain, Horst K.J. Baas, Thomas H. Müller, Peter Franz Riederer · 2017 · Journal of Neural Transmission
61. A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value
    Giuseppe Cosentino, Micol Avenali, Antonio Schindler, Nicole Pizzorni, Cristina Montomoli, Giovanni Abbruzzese, Angelo Antonini, Filippo Barbiera, Marco Benazzo, Eduardo Elias Benarroch et al. · 2021 · Journal of Neurology
62. The Role of Diet and Dietary Patterns in Parkinson’s Disease
    Emily Knight, Thangiah Geetha, Donna O. Burnett, Jeganathan Ramesh Babu · 2022 · Nutrients
63. Aberrant regional homogeneity in Parkinson’s disease: A voxel-wise meta-analysis of resting-state functional magnetic resonance imaging studies
    PingLei Pan, Hui Zhan, Mingxu Xia, Yang Zhang, Dening Guan, Yun Xu · 2016 · Neuroscience & Biobehavioral Reviews
64. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment
    Jennifer G. Goldman, Samantha K. Holden, Irene Litvan, Ian Grant McKeith, Glenn T. Stebbins, John‐Paul Taylor · 2018 · Movement Disorders
65. A critique of the second consensus criteria for multiple system atrophy
    Iva Stanković, Niall Patrick Quinn, Luca Vignatelli, Angelo Antonini, Daniela Berg, Elizabeth A. Coon, Pietro Cortelli, Alessandra Fanciulli, Joaquim José Ferreira, Roy L. Freeman et al. · 2019 · Movement Disorders
66. Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
    Daniele Belvisi, Roberta Pellicciari, Giovanni Fabbrini, Michèle Tinazzi, Alfredo Berardelli, Giovanni Defazio · 2019 · Neurobiology of Disease
67. SLC7A11 is an unconventional H+ transporter in lysosomes
    Nan Zhou, Jingzhi Chen, Meiqin Hu, Na Wen, Weijie Cai, Ping Li, Liding Zhao, Yaping Meng, Zhao Dongdong, Xiaotong Yang et al. · 2025 · Cell
68. Phytotherapy in treatment of Parkinson’s disease: a review
    Zahra Rabiei, Kamal Solati, Hossein Amini-Khoei · 2019 · Pharmaceutical Biology
69. The role of brain perivascular space burden in early-stage Parkinson’s disease
    Ting Shen, Yumei Yue, Shuai Zhao, Juan‐Juan Xie, Yanxing Chen, Jun Tian, Wen Lv, Chun‐Yi Zac Lo, Yi‐Cheng Hsu, Tobias Kober et al. · 2021 · npj Parkinson s Disease
70. Nicotinic acetylcholine receptors in neurological and psychiatric diseases
    Terry, Alvin V., Jones, Keri, Bertrand, Daniel · 2023 · Pharmacological Research
71. Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
    Ilaria Cova, Alberto Priori · 2018 · Journal of Neural Transmission
72. Development of early diagnosis of Parkinson's disease: Illusion or reality?
    Michael V. Ugrumov · 2020 · CNS Neuroscience & Therapeutics
73. Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS
    Carmen Rodríguez‐Blázquez, Anette E. Schrag, Alexandra Rizos, К. Ray Chaudhuri, Pablo Martínez‐Martín, Daniel A. Weintraub · 2020 · Movement Disorders Clinical Practice
74. Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning
    Anat Mirelman, Mor Ben-Or Frank, Michal Melamed, Lena Granovsky, Alice Nieuwboer, Lynn Rochester, Silvia Del Din, Laura Avanzino, Elisa Pelosin, Bastiaan R. Bloem et al. · 2021 · Movement Disorders
75. The overlap between Essential tremor and Parkinson disease
    Musleh Algarni, Alfonso A. Fasano · 2017 · Parkinsonism & Related Disorders
76. Oculo‐visual abnormalities in Parkinson's disease: Possible value as biomarkers
    Li Guo, Eduardo Maria Normando, Parth Arvind Shah, Lies De Groef, Maria Francesca Cordeiro · 2018 · Movement Disorders
77. Exosomes from patients with Parkinson’s disease are pathological in mice
    Chao Han, Nian Xiong, Xingfang Guo, Jinsha Huang, Kai Ma, Ling Liu, Yun Fei Xia, Yan Shen, Jie Li, Haiyang Jiang et al. · 2019 · Journal of Molecular Medicine
78. Alterations of gut microbiota and metabolome with Parkinson's disease
    Zhenzhen Yan, Fan Yang, Jingwei Cao, Wencai Ding, Shi Yan, Wanying Shi, Shirong Wen, Lifen Yao · 2021 · Microbial Pathogenesis
79. A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Rui Qi, Esther M. Sammler, Claudia P. González-Hunt, Ivana Barraza, Nicholas Pena, Jeremy P. Rouanet, Yahaira Naaldijk, Steven D. Goodson, Marie Fuzzati, Fabio Blandini et al. · 2023 · Science Translational Medicine
80. Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study
    Rosa Manenti, Maria Sofia Cotelli, Chiara Cobelli, Elena Gobbi, Michela Brambilla, Danila Rusich, Antonella Alberici, Alessandro Padovani, Barbara Borroni, Maria Cotelli · 2018 · Brain stimulation
81. Non‐motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life
    Xinxin Huang, Samuel Yong‐Ern Ng, Nicole Shuang Yu Chia, F. Setiawan, Kay Yaw Tay, Wing‐Lok Au, Eng‐King Tan, L. C. S. Tan · 2018 · European Journal of Neurology
82. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis
    F. Albrecht, T. Ballarini, J. Neumann, M. Schroeter · 2018 · NeuroImage: Clinical
83. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy
    Giorgio Vivacqua, Antonio Suppa, Romina Mancinelli, Daniele Belvisi, Andrea Fabbrini, Matteo Costanzo, Alessandra Formica, Paolo Onori, Giovanni Fabbrini, Alfredo Berardelli · 2019 · Parkinsonism & Related Disorders
84. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson’s Disease Subtypes
    Karoline Knudsen, Tatyana Dmitrievna Fedorova, Jacob Horsager, Katrine B. Andersen, Casper Skjærbæk, Daniela Berg, Eva Schaeffer, David James Brooks, Nicola Pavese, Nathalie Van Den Berge et al. · 2021 · Journal of Parkinson s Disease
85. Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review
    Giovanni Palermo, Sara Giannoni, Gabriele Bellini, Gabriele Siciliano, Roberto Ceravolo · 2021 · International Journal of Molecular Sciences
86. Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
    Lorenzo Barba, Federico Paolini Paoletti, Giovanni Bellomo, Lorenzo Gaetani, Steffen Halbgebauer, Patrick Oeckl, Markus Otto, Lucilla Parnetti · 2022 · Movement Disorders
87. Redefining Bradykinesia
    Matteo Bologna, Alberto Javier Espay, Alfonso A. Fasano, Giulia Paparella, Mark Hallett, Alfredo Berardelli · 2023 · Movement Disorders
88. Metabolic Imaging in Parkinson Disease
    Sanne K. Meles, Laura K. Teune, Bauke M. de Jong, Rudi A. J. O. Dierckx, Klaus Leonhard Leenders · 2016 · Journal of Nuclear Medicine
89. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
    Inga Zerr, Matthias Schmitz, André Karch, Anna Villar‐Piqué, Ειrini Kanata, Ewa Golańska, Daniela Diaz Lucena, Aikaterini Karsanidou, Péter Hermann, Tobias Knipper et al. · 2018 · Alzheimer s & Dementia
90. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies
    Alan J. Thomas, Paul C. Donaghy, Gemma Roberts, Sean J. Colloby, Nicky A. Barnett, George S. Petrides, Jim J. Lloyd, Kirsty Olsen, John‐Paul Taylor, Ian Grant McKeith et al. · 2018 · Psychological Medicine
91. What a neurologist should know about depression in Parkinson’s disease
    Monique H.M. Timmer, Marleen H.C.T. Van Beek, Bas R. Bloem, Rianne A.J. Esselink · 2017 · Practical Neurology
92. The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
    Géraldine Hipp, Michel Vaillant, Nico J. Diederich, Kirsten Roomp, Venkata Satagopam, Peter Banda, Estelle Sandt, Kathleen Mommaerts, Sabine K. Schmitz, Laura Longhino et al. · 2018 · Frontiers in Aging Neuroscience
93. Smartwatch for the analysis of rest tremor in patients with Parkinson's disease
    Roberto López Blanco, Miguel A. Velasco, Antonio Méndez-Guerrero, Juan Pablo Romero, M. Dolores del Castillo, José Ignacio Serrano, Eduardo Rocón, Julián Benito‐León · 2019 · Journal of the Neurological Sciences
94. Parkinson Disease
    Houman Homayoun · 2018 · Annals of Internal Medicine
95. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ <scp> ¹¹ C </scp> ] <scp>UCB‐J PET</scp> Imaging Study
    Andersen, Katrine B., Hansen, Allan K., Damholdt, Malene F., Horsager, Jacob, Skjærbæk, Casper, Gottrup, Hanne, Klit, Henriette, Schacht, Anna Christina, Danielsen, Erik H., Brooks, David J. et al. · 2021 · Movement Disorders
96. Parkinson Disease
    Theresa Zesiewicz · 2019 · CONTINUUM Lifelong Learning in Neurology
97. Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
    Shuanglong Yi, Lin-Fang Wang, Honglei Wang, M. Ho, Shi-Ping Zhang · 2022 · International Journal of Molecular Sciences
98. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders
    Bárbara Fernandes Gomes, Carly M. Farris, Yihua Ma, Luis Concha‐Marambio, Russ M. Lebovitz, Bengt Nellgård, Keti Dalla, Julius Constantinescu, Radu Constantinescu, Johan Gobom et al. · 2023 · Parkinsonism & Related Disorders
99. Bradykinesia in early and advanced Parkinson's disease
    Matteo Bologna, Giorgio Leodori, Paola Stirpe, Giulia Paparella, Donato Colella, Daniele Belvisi, Alfonso A. Fasano, Giovanni Fabbrini, Alfredo Berardelli · 2016 · Journal of the Neurological Sciences
100. Traumatic Brain Injury and Risk of Long-Term Brain Changes, Accumulation of Pathological Markers, and Developing Dementia: A Review
     LoBue, Christian, Munro, Catherine, Schaffert, Jeffrey, Didehbani, Nyaz, Hart,, John, Batjer, Hunt, Cullum, C. Munro · 2019 · Journal of Alzheimer's Disease